Beijing Ql Biopharmaceutical Co.,ltd

This study tested whether a new injection called ZT002 helps people with overweight or obesity lose weight. 303 adults received either the injection or a placebo for 24 weeks. Researchers measured how much weight participants lost and checked the treatment's safety.

This was an early-stage study to check the safety and drug levels of a new injection called ZT002 in people with overweight or obesity. Twenty-eight adults received either the drug or a placebo (dummy injection) in increasing doses. The main goal was to see how well the body hand…

This was an early-stage study to check the safety and basic effects of a new oral medication called ZT006, which is being developed to help manage weight. It involved 94 healthy adults who were overweight or obese. Researchers tested single and multiple doses to see how the body …